Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Allergy and Immunology · Chronic Spontaneous Urticaria

Why Are Long-Term Steroids Avoided for Chronic Urticaria?

At a Glance

Long-term or repeated systemic steroids can temporarily calm chronic spontaneous urticaria but do not provide dependable long-term control and can cause bone loss, weight gain, high blood sugar, infections, and reduced natural steroid production. Guidelines favor antihistamines and steroid-sparing treatments.

Chronic Spontaneous Urticaria (CSU) is a condition where itchy, swollen hives appear unpredictably for at least six weeks without a consistent external trigger. When you are suffering from a severe flare-up, systemic (body-wide) corticosteroids like prednisone can temporarily reduce symptoms and provide rapid relief.

However, international treatment guidelines (such as those from the EAACI/GA²LEN/EuroGuiDerm/APAAACI) strongly advise against using systemic steroids for long-term maintenance [1]. While doctors may prescribe a short “rescue” burst during a severe exacerbation, prolonged or repeated courses do not provide sustainable control of the underlying disease and come with cumulative, serious risks [1] [2].

EMERGENCY WARNING
If your hives are accompanied by trouble breathing, difficulty swallowing, swelling of the throat or tongue, or fainting, seek emergency medical care immediately. These can be signs of a life-threatening allergic reaction (anaphylaxis) or dangerous angioedema. Use prescribed epinephrine if you have it. Prednisone is not a substitute for emergency treatment.

The Short-Term Relief vs. Long-Term Reality

Relying on repeated courses of steroids signals that your hives are not adequately controlled. Real-world observational data shows an association between systemic corticosteroid prescriptions in CSU patients and higher rates of adverse medical events and healthcare utilization [3]. While patients who receive steroids often have more severe disease to begin with, the risks of the medication itself become a major factor over time.

DO NOT STOP ABRUPTLY
If you have been taking systemic steroids continuously for a prolonged period, do not stop taking them abruptly or change your dose without medical supervision. Prolonged use can cause adrenal suppression (where your body stops making its own natural steroids). Your clinician must design a safe, individualized tapering plan to wean you off safely.

Severe Side Effects of Prolonged Use

The risk of side effects from systemic steroids generally increases with the dose, the duration of use, and the number of repeated courses you take [4].

  • Bone Density Loss and Fractures: Glucocorticoid-induced bone loss can begin rapidly after starting treatment. Doses as low as 2.5 mg per day of prednisone (or equivalent) for more than three months are considered a threshold where doctors should assess you for fracture risk [5]. Prolonged exposure leads to a dose-dependent increase in fracture risk [6] [7].
  • Weight Gain and Appearance Changes: Prolonged steroid exposure is heavily associated with excessive weight gain and Cushingoid features, which include a rounded face or fatty deposits on the back of the neck [8] [9] [10].
  • Diabetes and Blood Sugar: Steroids interfere with how your body processes glucose. They can worsen your glucose tolerance within just a few weeks and are associated with a dose-dependent risk of developing diabetes [7] [11] [12].
  • Immune Suppression and Infections: Steroids suppress your immune system, which increases your risk of opportunistic infections (infections, like shingles, that take advantage of a weakened immune system) [13]. While these risks are much higher with prolonged or high-dose treatment, even daily doses below 5 mg are not entirely risk-free [14].

Because the risks of long-term steroids outweigh the benefits, guidelines outline a safer, stepwise approach to treating chronic hives (though specific medication approvals can vary by country) [1]:

  1. Optimized Antihistamines: Standard second-generation H1-antihistamines (like cetirizine or fexofenadine) are the first-line treatment. If standard doses fail, a clinician may direct you to increase the dose up to four times the approved amount [15] [16]. Do not self-escalate your dose. This must be clinician-directed, as some antihistamines can cause sedation, impair driving, or interact with other drugs.
  2. Biologic Therapies: If symptoms persist despite maximized antihistamines, guidelines suggest adding omalizumab, an anti-IgE biologic (a medication derived from living cells that targets specific immune pathways) [2] [15]. It requires medical administration and carries a rare risk of hypersensitivity reactions.
  3. Specialist-Monitored Immunosuppressants: For severe, resistant CSU, medications like cyclosporine may be used as a steroid-sparing option [17]. This is often an off-label use and requires close specialist monitoring for serious risks, including kidney dysfunction, high blood pressure, and drug interactions [17].

If your hives are not well-controlled without frequent prednisone, referral to a specialist—such as an allergist, immunologist, or dermatologist—is highly appropriate. Patients who see specialists are more likely to receive advanced, guideline-recommended biologic treatments and a clear long-term plan [16] [18].

Common questions in this guide

Why shouldn't I take prednisone long term for chronic hives?
Prednisone and other systemic steroids can calm hives quickly, but prolonged or repeated use does not provide dependable long-term control. Cumulative risks include bone loss, fractures, weight gain, high blood sugar, infections, and suppression of the body's natural steroid production.
Can prednisone be used during a severe chronic urticaria flare?
A clinician may prescribe a short rescue course for a severe flare, but systemic steroids are not recommended as ongoing maintenance treatment. If you need prednisone repeatedly, ask about a stepwise plan to control the hives and reduce steroid exposure.
What health problems can long-term steroid use cause?
The risk rises with higher doses, longer treatment, and repeated courses. Possible problems include reduced bone density and fractures, weight and appearance changes, diabetes or high blood sugar, infections, and adrenal suppression.
What treatments can be used instead of long-term steroids for chronic hives?
Guidelines generally start with a second-generation H1-antihistamine, with dose increases only when directed by a clinician. If symptoms continue, omalizumab may be added, and cyclosporine may be considered for severe resistant disease with close specialist monitoring.
How should I stop prednisone after taking it for a long time?
Do not stop systemic steroids abruptly after prolonged use because your body may not be making enough of its own natural steroids. The prescribing clinician should create an individualized tapering plan and monitor you during the dose reduction.
When do hives require emergency medical care?
Trouble breathing, difficulty swallowing, swelling of the throat or tongue, or fainting may signal anaphylaxis or dangerous angioedema. Seek emergency care immediately and use prescribed epinephrine if available; prednisone is not a substitute for emergency treatment.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on chronic urticaria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many times have I used a steroid course for my hives recently, and does my total exposure justify screening for bone density or blood sugar changes?
  2. 2.Which specific daily antihistamine should I take, at what dose, and what side effects (like drowsiness) should I watch for?
  3. 3.What is our exact step-by-step plan if my current daily medication is not controlling my flare-ups?
  4. 4.Given my medical history, what specific monitoring would I need if we start advanced therapies like omalizumab or cyclosporine?

References

References (18)
  1. 1

    Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.

    Hon KL, Li JTS, Leung AKC, Lee VWY

    Expert opinion on pharmacotherapy 2021; (22(4)):497-509 doi:10.1080/14656566.2020.1829593.

    PMID: 32990110
  2. 2

    Chronic Spontaneous Urticaria: A Review.

    Kolkhir P, Bonnekoh H, Metz M, Maurer M

    JAMA 2024; (332(17)):1464-1477 doi:10.1001/jama.2024.15568.

    PMID: 39325444
  3. 3

    Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study.

    Yosipovitch G, Patil D, Rodrigues J, et al.

    Dermatology and therapy 2026; (16(8)):3905-3918 doi:10.1007/s13555-026-01776-0.

    PMID: 42084779
  4. 4

    Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

    Scheire S, Lourijsen E, Blauwblomme M, et al.

    Allergy 2026; (81(9)):3071-3106 doi:10.1111/all.70332.

    PMID: 42011838
  5. 5

    Management of glucocorticoid-induced osteoporosis.

    Messina OD, Vidal LF, Wilman MV, et al.

    Aging clinical and experimental research 2021; (33(4)):793-804 doi:10.1007/s40520-021-01823-0.

    PMID: 33751462
  6. 6

    Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.

    Compston JE

    European journal of endocrinology 2023; (188(3)):R46-R55 doi:10.1093/ejendo/lvad029.

    PMID: 36880157
  7. 7

    Treatment patterns and impact of glucocorticoids on health outcomes in generalized myasthenia gravis: a retrospective observational study based on the Medical Data Vision database in Japan.

    Teranishi H, Tsuda K, Harada D, et al.

    Frontiers in neurology 2025; (16()):1625457 doi:10.3389/fneur.2025.1625457.

    PMID: 41142144
  8. 8

    Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study.

    Cai L, Li G, Abdulaziz AT, et al.

    Epilepsia 2024; (65(11)):3199-3215 doi:10.1111/epi.18107.

    PMID: 39324872
  9. 9

    Corticosteroids for the treatment of Duchenne muscular dystrophy.

    Matthews E, Brassington R, Kuntzer T, et al.

    The Cochrane database of systematic reviews 2016; CD003725 doi:10.1002/14651858.CD003725.pub4.

    PMID: 27149418
  10. 10

    Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence.

    Möhlmann JE, Ezzafzafi S, Lindemans CA, et al.

    Clinical pharmacokinetics 2024; (63(9)):1251-1270 doi:10.1007/s40262-024-01419-7.

    PMID: 39264575
  11. 11

    MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia

    Radhakutty A, Burt MG

    European journal of endocrinology 2018; (179(4)):R207-R218 doi:10.1530/EJE-18-0315.

    PMID: 30299889
  12. 12

    Clinical Impact of High-Dose Corticosteroids on Healthcare Resource Utilization and Steroid-Related Complications in Patients with Myasthenia Gravis in Japan.

    Numajiri N, Yamamoto T, Waratani M, Takahashi MP

    Neurology and therapy 2025; doi:10.1007/s40120-025-00850-7.

    PMID: 41219665
  13. 13

    Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.

    Yang SC, Lai YY, Huang MC, et al.

    Lupus 2018; (27(11)):1819-1827 doi:10.1177/0961203318792352.

    PMID: 30103646
  14. 14

    Case Report: Simultaneous presence of Sarcoptes scabiei and fungal elements in scrapings from a patient with bullous pemphigoid.

    Ye Y, Lv W, Chai L, et al.

    Frontiers in medicine 2026; (13()):1773134 doi:10.3389/fmed.2026.1773134.

    PMID: 41877790
  15. 15

    Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.

    Vestergaard C, Toubi E, Maurer M, et al.

    European journal of dermatology : EJD 2017; (27(1)):10-19 doi:10.1684/ejd.2016.2905.

    PMID: 27882879
  16. 16

    [Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].

    Costa C, Gonçalo M,

    Acta medica portuguesa 2016; (29(11)):763-781 doi:10.20344/amp.8294.

    PMID: 28229846
  17. 17

    Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.

    Kocatürk E, Chu DK, Türk M, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(9)):2252-2269 doi:10.1016/j.jaip.2025.07.021.

    PMID: 40815254
  18. 18

    Specialist care improves diagnosis and treatment for patients with chronic spontaneous urticaria: A real-world survey.

    Mosnaim G, Hetherington J, Keal A, et al.

    The journal of allergy and clinical immunology. Global 2026; (5(1)):100573 doi:10.1016/j.jacig.2025.100573.

    PMID: 41210911

This page is for informational purposes only and is not medical advice. Do not stop or change systemic steroids without clinician guidance, and seek emergency care for breathing problems or throat or tongue swelling.